WS13.5 Pharmacokinetics and safety of once daily double dose inhaled tobramycin administered with the controlled-inhalation AKITA® and conventional PARI-LC® Plus nebulizer in cystic fibrosis
van Velzen, A.J., Bos, A.C., Touw, D.J., Tiddens, H.A.W.M., Heijerman, H.G.M., Janssens, H.M.Volume:
14
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(15)30083-7
Date:
June, 2015
File:
PDF, 54 KB
english, 2015